Insmed Inc (NASDAQ: INSM) started the day on Thursday, with a price decrease of -16.08% at $166.55, before settling in for the price of $198.46 at the close. Taking a more long-term approach, INSM posted a 52-week range of $60.40-$212.75.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -13.12%. Meanwhile, its Annual Earning per share during the time was -13.12%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -8.50%. This publicly-traded company’s shares outstanding now amounts to $212.58 million, simultaneously with a float of $210.36 million. The organization now has a market capitalization sitting at $35.52 billion. At the time of writing, stock’s 50-day Moving Average stood at $186.64, while the 200-day Moving Average is $121.17.
Insmed Inc (INSM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Insmed Inc’s current insider ownership accounts for 1.37%, in contrast to 100.29% institutional ownership. Preceding that transaction, on Dec 05 ’25, Company’s Director sold 20,000 for 205.01, making the whole transaction’s value amount to 4,100,200. This particular insider is now the holder of 243,948 in total.
Insmed Inc (INSM) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.18 per share during the current fiscal year.
Insmed Inc’s EPS decrease for this current 12-month fiscal period is -8.50% and is forecasted to reach -3.41 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 52.40% through the next 5 years, which can be compared against the -13.12% growth it accomplished over the previous five years trading on the market.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Let’s observe the current performance indicators for Insmed Inc (INSM). It’s Quick Ratio in the last reported quarter now stands at 4.34. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 79.46.
In the same vein, INSM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.18, a figure that is expected to reach -1.28 in the next quarter, and analysts are predicting that it will be -3.41 at the market close of one year from today.
Technical Analysis of Insmed Inc (INSM)
If we take a close look at the recent performances of Insmed Inc (NASDAQ: INSM), its last 5-days Average volume was 5.53 million that shows progress from its year to date volume of 2.72 million. During the previous 9 days, stock’s Stochastic %D was recorded 40.54% While, its Average True Range was 21.62.
Raw Stochastic average of Insmed Inc (INSM) in the period of the previous 100 days is set at 57.71%, which indicates a major rise in contrast to 10.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 7.18 that was higher than 5.33 volatility it exhibited in the past 100-days period.
